Literature DB >> 4271773

Platelet aggregation and cryo-IgM in the study of hepatitis and immune complex states.

K Penttinen, O Wager, J A Räsänen, G Myllylä, E Haapanen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4271773      PMCID: PMC1553893     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  9 in total

1.  PLATELET SEQUESTRATION IN MAN. I. METHODS.

Authors:  R H ASTER; J H JANDL
Journal:  J Clin Invest       Date:  1964-05       Impact factor: 14.808

2.  Detection and characterization of immune complexes by the platelet aggregation test. II. Circulating complexes.

Authors:  G Myllylä; A Vaheri; K Penttinen
Journal:  Clin Exp Immunol       Date:  1971-03       Impact factor: 4.330

3.  Localization of Gm markers to different molecular regions of the Fc fragment.

Authors:  J B Natvig; M W Turner
Journal:  Clin Exp Immunol       Date:  1971-05       Impact factor: 4.330

4.  Mixed cryoimmunoglobulinaemia in infectious mononucleois and Cytomegalovirus mononucleosis.

Authors:  O Wager; J A Räsänen; A Hagman; E Klemola
Journal:  Int Arch Allergy Appl Immunol       Date:  1968

5.  Platelet aggregation test in the study of hepatitis.

Authors:  K Penttinen
Journal:  Am J Dis Child       Date:  1972-04

6.  Anticomplementary activity in serological tests for syphilis as a clue to connective tissue diseases of an auto-immune nature.

Authors:  A Lassus; K K Mustakallio
Journal:  Ann Clin Res       Date:  1969-05

7.  Soluble antigen-antibody complexes and platelet aggregation.

Authors:  K Penttinen; G Myllylä; O Mäkelä; A Vaheri
Journal:  Acta Pathol Microbiol Scand       Date:  1969

8.  Detection and characterization of immune complexes by the platelet aggregation test. I. Complexes formed in vitro.

Authors:  K Penttinen; A Vaheri; G Myllylä
Journal:  Clin Exp Immunol       Date:  1971-03       Impact factor: 4.330

9.  Inhibition of IgG complex-induced platelet aggregation by antiglobulin-active cryoglobulin IgM components.

Authors:  O Wager; K Penttinen; J A Räsänen; G Myllylä
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

  9 in total
  9 in total

1.  Circulating complexes in leprosy studied by the platelet aggregation test. The platelet aggregation test and its relation to the Rubino test and other sero-immunological parameters in 135 patients with leprosy.

Authors:  O Wager; K Penttinen; J D Almeida; D V Opromolla; T Godal; G Kronvall
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

2.  Evidence for circulating immune complexes in sarcoidosis.

Authors:  E Hedfors; R Norberg
Journal:  Clin Exp Immunol       Date:  1974-03       Impact factor: 4.330

3.  Immune reactions of platelets and their clinical significance.

Authors:  C Mueller-Eckhardt
Journal:  Klin Wochenschr       Date:  1975-10-01

4.  Inhibition of IgG complex-induced platelet aggregation by antiglobulin-active cryoglobulin IgM components.

Authors:  O Wager; K Penttinen; J A Räsänen; G Myllylä
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

5.  Platelet aggregation by isolated and aggregated human IgG.

Authors:  T Palosuo; J Leikola
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

6.  Immune complexes in early arthritis. L Detection of immune complexes before rheumatoid arthritis is definite.

Authors:  V E Jones; R K Jacoby; T Wallington; P Holt
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

7.  Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series.

Authors:  O Wager; P Lindström; J A Räsänen; R Kekomäki; B Ziola; A Salmi; H Isomäki; B Skrifvars; K Penttinen
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

8.  Complement-fixing material in ther sera of patients with rheumatoid arthritis.

Authors:  F C McDuffie; G G Hunder; R J Clark
Journal:  Clin Exp Immunol       Date:  1978-05       Impact factor: 4.330

9.  Gold nephropathy: serologic data suggesting an immune complex disease.

Authors:  T Palosuo; T T Provost; F Milgrom
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.